Early-Life Nutritional Determinants of Pediatric MASLD. [PDF]
DiStefano JK.
europepmc +1 more source
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology [PDF]
Paola Loria +7 more
openalex +1 more source
Effectiveness of Saroglitazar in MASLD Patients: A Prospective, Real-World Assessment of Liver and Metabolic Health. [PDF]
Gupta M +4 more
europepmc +1 more source
Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C Virus [PDF]
Tinsay A. Woreta +8 more
openalex +1 more source
Ultrasound-guided attenuation parameter for hepatic steatosis quantification in psoriasis: a retrospective cohort study: Quantitatively evaluate of hepatic steatosis. [PDF]
Wang X +5 more
europepmc +1 more source
ChREBP refines the hepatic response to fructose to protect the liver from injury [PDF]
Angela M. Hall +3 more
core +3 more sources
From fatty liver indices to the Zhejiang University index: Re-shaping risk stratification of metabolic liver disease in diabetes. [PDF]
Gouda MM.
europepmc +1 more source
Retraction: Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar. [PDF]
PLOS One Editors.
europepmc +1 more source

